# Summit Biosciences Inc. - Inspection Records

Source: https://www.keypedia.com/companies/summit-biosciences-inc/2dadddc5-06ce-43be-914b-1b6e9a76e976

> Inspection records and compliance data for Summit Biosciences Inc. in Lexington, Kentucky. Access full analysis and detailed observations.

---

## Details

- Name: Summit Biosciences Inc.
- FEI Number: 3007577023
- City: Lexington
- State: Kentucky
- Country Name: United States
- Address Line 1: 1513 Bull Lea Rd
- Zip Code: 40511
- Business Operations: FDF MANUFACTURE

## Related Documents

- [483 - Summit Biosciences Inc. - 2025-02-21](https://www.keypedia.com/records/483/summit-biosciences-inc/f1c02c76-4a6d-4a2a-96f8-502730a91773) — source: FDA, date: February 21, 2025
- [FDA Inspection 1261583 - Summit Biosciences Inc. - 2025-02-21](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/fbf78c84-7d7e-4694-9f67-ee101159342d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 21, 2025
- [FDA Inspection 1218227 - Summit Biosciences Inc. - 2023-09-14](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/4dfd068f-13de-4321-897b-877c72d3592b) — classification: No Action Indicated (NAI), source: FDA, date: September 14, 2023
- [FDA Inspection 1121348 - Summit Biosciences Inc. - 2020-02-04](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/19d10378-051a-47ff-b8a8-b4e78e1d0333) — classification: No Action Indicated (NAI), source: FDA, date: February 4, 2020
- [FDA Inspection 1018004 - Summit Biosciences Inc. - 2017-06-23](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/c0f4cc8b-fd56-4d6f-8d17-f9e0da7f4f8a) — classification: No Action Indicated (NAI), source: FDA, date: June 23, 2017
- [FDA Inspection 933643 - Summit Biosciences Inc. - 2015-06-18](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/57f4ace6-9ae3-4f29-8fe5-f8e2e4db37e2) — classification: No Action Indicated (NAI), source: FDA, date: June 18, 2015
- [FDA Inspection 868633 - Summit Biosciences Inc. - 2014-02-28](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/38015c8a-d915-445e-93fb-f6c08c9fe811) — classification: No Action Indicated (NAI), source: FDA, date: February 28, 2014

## Related Companies

- [AstraZeneca AB](https://www.keypedia.com/companies/astrazeneca-ab/b85a1aa5-9a0c-4c1e-996d-70b40b2507de)
- [Ingenus Pharmaceuticals NJ, LLC.](https://www.keypedia.com/companies/ingenus-pharmaceuticals-nj-llc/542b7622-3ecf-48db-9fc6-0edf6cc42665)
- [Becton Dickinson Infusion Therapy Systems, Inc.](https://www.keypedia.com/companies/becton-dickinson-infusion-therapy-systems-inc/d0e73e32-eca1-4137-8dfc-d6bde32ba0aa)
- [Actavis Laboratories FL, Inc.](https://www.keypedia.com/companies/actavis-laboratories-fl-inc/7c50db23-6cc7-4100-bc80-c02d3aa7f85a)
- [Mipharm S.p.A.](https://www.keypedia.com/companies/mipharm-spa/5bbbfcd9-7f44-434e-a097-60a4d9f446bc)
- [Colgate-Palmolive Company](https://www.keypedia.com/companies/colgate-palmolive-company/7db665f6-094f-4de5-bf3b-c2528e2a223b)
- [Rovi Pharma Industrial Services S.A.](https://www.keypedia.com/companies/rovi-pharma-industrial-services-sa/92dc52fe-a8d7-4a23-bc34-be68892d8866)
- [Procaps S.A.](https://www.keypedia.com/companies/procaps-sa/55857dcf-eb79-4f64-b7ea-39d009cb5298)
- [Eisai, Inc.](https://www.keypedia.com/companies/eisai-inc/1e0d6af4-f962-4ac0-826f-90ce5f71a0a3)
- [Sanofi Winthrop Industrie](https://www.keypedia.com/companies/sanofi-winthrop-industrie/88a4c8ee-d792-4747-acb7-de304d1efbb6)

## Related Officers

- [Ucheabuchi C. Chudi-nwankwor](https://www.keypedia.com/people/ucheabuchi-c-chudi-nwankwor/18b01d08-3cfd-4ace-97b2-5f54b6427661)